General Updates

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL AXIS/CO/CS/242/2026-27 July 14, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, P. J. Towers, Plot No. C/1, “G” Block Dalal Street Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 NSE Symbol: AXISBANK BSE Scrip Code: 532215 Dear Sir/Madam, Sub.: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended In furtherance to our letter bearing reference number AXIS/CO/CS/493/2025-26 dated December 26, 2025, AXIS/CO/CS/227/2026-27 dated July 7, 2026 and AXIS/CO/CS/241/2026-27 dated July 14, 2026, this is to inform you that the Bank has received the final listing approval from the Global Securities Market of the India International Exchange (IFSC) Limited (“India INX”) pursuant to letter bearing reference number 20260714-3 dated July 14, 2026 and Debt Securities Market of the NSE IFSC Limited (“NSE IX”) pursuant to letter bearing reference number NSEIFSC/TRADE/20/2026 dated July 14, 2026, for the listing of US$100,000,000 6.875% Additional Tier 1 Notes (“ AT 1 Notes”). The said AT 1 Notes will be consolidated and form a single series with the U.S.$500,000,000 6.875 per cent. Additional Tier 1 Notes issued on June 30, 2026. The pricing supplements (“Pricing Supplements”) are available on the websites of India INX and NSE IX at the following weblinks, respectively: • https://www.indiainx.com/static/issuer_details.aspx • https://www.nseix.com/listing/issuer-details This is for information of all concerned in compliance with the applicable provisions of the Listing Regulations. Thanking you, With warm regards, For Axis Bank Limited Sandeep Poddar Company Secretary CC: London Stock Exchange Singapore Stock Exchange DISCLAIMER: The offering circular dated December 26, 2025 (“Offering Circular”) and Pricing Supplements for the GMTN Programme have not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Securities and Exchange Board of India, the relevant Registrar of Companies, or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum, general information document, key information document or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules thereunder or any other applicable Indian laws. The Offering Circular and Pricing Supplements have not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the relevant Registrar of Companies, the Securities and Exchange Board of India, the Reserve Bank of India, or any recognised stock exchange in India. The Offering Circular is not mand should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India. The Notes have not been and will not be, offered or sold to any person resident in India. The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state of the United States or any other jurisdiction and the Notes may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws.s